Cystic fibrosis is the most common autosomal recessive disease among people of Northern European descent, with an average life expectancy of 30 years. It is caused by mutations in the CFTR gene, which codes for a chloride channel protein. The most common mutation, ΔF508, causes a processing defect that results in reduced chloride transport. Over 1000 mutations in CFTR have been identified. While treatments aim to address symptoms, gene therapy may someday deliver a corrected version of the gene.